AIM ImmunoTech to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
AIM ImmunoTech Inc. (AIM)
Company Research
Source: Yahoo! Finance
Equels will participate in two upcoming investor conferences. Details for the presentations are as follows: Event: Healthcare Company Showcase hosted by Alliance Global Partners Date and Time: Tuesday, May 21, 2024, at 3:20 PM ET Webcast Link Event: LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar Date and Time : Wednesday, May 22, 2024, at 3:40 PM ET Webcast Link Live webcasts of the presentations will be accessible on the Events page of the Investors section of the Company's website, aimimmuno.com About AIM ImmunoTech Inc. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company's lead product is a first-in-class investigational drug called Ampligen ® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally import
Show less
Read more
Impact Snapshot
Event Time:
AIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AIM alerts
High impacting AIM ImmunoTech Inc. news events
Weekly update
A roundup of the hottest topics
AIM
News
- AIM ImmunoTech to Participate in the Virtual Investor Pitch ConferenceGlobeNewswire
- AIM ImmunoTech to Participate in the Virtual Investor Lunch Break SeriesGlobeNewswire
- AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct OfferingGlobeNewswire
- AIM ImmunoTech to Participate in Two Upcoming Investor ConferencesGlobeNewswire
AIM
Sec Filings
- 6/3/24 - Form 8-K
- 6/3/24 - Form 424B5
- 5/31/24 - Form 424B5
- AIM's page on the SEC website